FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns an adjuvant immunogenic composition containing meningococcal lipooligosaccharide (LOS) and serotype 14 pneumococcal capsular saccharide (CS14), wherein CS14 contains tetrasaccharide Galβ1-4GlcNAcβ1-3Galβ1-4Glc, while LOS is free from tetrasaccharide Galβ1-4GlcNAcβ1-3Galβ1-4Glc. The group of inventions also concerns a method for inducing the immune response in a mammal involving administering the above composition.
EFFECT: group of inventions provides the stronger immune response to CS14 A as compared to wild-type OMV containing LNnT.
15 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS OF MENINGOCOCCAL FACTOR-H-BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES | 2010 |
|
RU2555757C2 |
| FACTOR H-BINDING ADJUVANT MENINGOCOCCAL PROTEIN | 2010 |
|
RU2557315C2 |
| LIQUID VACCINES FOR MULTIPLE MENINGOCOCCAL SEROGROUPS | 2004 |
|
RU2378010C2 |
| VACCINES FOR SEROGROUP X MENINGOCOCCUS | 2013 |
|
RU2644340C2 |
| LIQUID VACCINE FOR MULTIPLE SEROGROUPS OF MENINGOCOCCUS | 2009 |
|
RU2595845C2 |
| MENINGOCOCCAL fHBP POLYPEPTIDES | 2009 |
|
RU2475496C2 |
| POLYPEPTIDE VACCINES FOR WIDE PROTECTION AGAINST ROWS OF MENINGOCOCCUS GENERATIONS WITH INCREASED VIRULENCE | 2003 |
|
RU2333007C2 |
| MENINGOCOCCAL fHBP POLYPEPTIDES | 2012 |
|
RU2567003C2 |
| MULTIPLE VERSIONS OF MENINGOCOCCAL PROTEIN NMB 1870 | 2003 |
|
RU2336091C2 |
| MOLECULE CONTAINING spr0096 AND spr2021 | 2012 |
|
RU2636350C2 |
